Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon

Full text
Author(s):
Show less -
Gomes, Laura Cordeiro [1] ; Sanson, Marina Cordeiro Gomes [2] ; Brainin, Philip [3] ; de Melo, Maria da Conceicao Vieira [2] ; de Souza, Rodrigo Medeiros [2] ; Mazaro, Janaina [4] ; Lima, Karine Oliveira [2] ; Resende, Junia Silva [2] ; Vieira, Isabelle Victoria Martins [2] ; Mesquita, Edinilson da Silva [2] ; Matos, Luan Oliveira [2] ; Dutra, Isabelle Caroline Silva [2] ; Palmisano, Giuseppe [5] ; Wrenger, Carsten [5] ; Marinho, Claudio Romero Farias [5] ; da Silva, Rita do Socorro Uchoa [1]
Total Authors: 16
Affiliation:
[1] Univ Fed Acre, Hlth & Sport Sci Ctr, Rio Branco, Acre - Brazil
[2] Univ Fed Acre, Multidisciplinary Ctr, Cruzeiro Do Sul, Acre - Brazil
[3] Herlev Gentofte Univ Hosp, Hellerup - Denmark
[4] Lab Publ Hlth Acre, Cruzeiro Do Sul, Acre - Brazil
[5] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo - Brazil
Total Affiliations: 5
Document type: Journal article
Source: PLoS One; v. 16, n. 7 2021.
Web of Science Citations: 0
Abstract

Background Despite completion of the vaccine schedule for hepatitis B virus (HBV), children may display levels of HBV surface antibodies (anti-HBs) that are considered inadequate for sufficient protection (<10 IU/L). Aims Our aim was to investigate if age and gap time between HBV vaccine doses may negatively affect the levels of anti-HBs in children, and if these relationships are modified by sex. Methods In a high-endemic HBV region of the western Brazilian Amazon we enrolled children who had completed the HBV vaccine schedule. All children underwent analysis of anti-HBs and a clinical examination. Results We included 522 children (mean age 4.3 +/- 0.8 years; 50% male). Median anti-HBs was 28.4 {[}interquartile range (IQR) 5.4 to 128.6] IU/L and 32% had anti-HBs <10 IU/L. The median gap time from last to preceding dose was 2.4 {[}IQR 2.1 to 3.3] months. Levels of anti-HBs decreased with higher age (-42% per year increase {[}95%CI -56% to -24%], p<0.001), but not with longer gap time (+23% per month increase {[}95%CI -16% to +62%], p = 0.249). After adjusting for relevant confounders, gap time became significant (p = 0.032) and age remained a significant predictor of anti-HBs (p<0.001). Conclusion One third of assessed children displayed anti-HBs <10 IU/L. Levels of anti-HBs decreased with higher age and increased with longer gap time between the last two doses. (AU)

FAPESP's process: 18/20468-0 - Recrudescence of the malaria during pregnancy: effects and mechanisms
Grantee:Cláudio Romero Farias Marinho
Support Opportunities: Regular Research Grants
FAPESP's process: 18/18257-1 - Multi-user equipment approved in grant 14/06863-3: HPLC system configured for analysis of carbohydrates, amino acidis, peptides and glycoproteins
Grantee:Giuseppe Palmisano
Support Opportunities: Multi-user Equipment Program
FAPESP's process: 18/15549-1 - Post-translational modifications in Chagas Disease biological processes and diagnostics: novel methodological approaches and biological applications
Grantee:Giuseppe Palmisano
Support Opportunities: Research Grants - Young Investigators Grants - Phase 2
FAPESP's process: 15/26722-8 - Drug discovery against human infectious diseases
Grantee:Carsten Wrenger
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 14/06863-3 - Post-translational modifications in cancer and parasite infection diagnosis: methodological approaches and biological implications
Grantee:Giuseppe Palmisano
Support Opportunities: Research Grants - Young Investigators Grants